Method for synthesizing chiral pentabasic carbocyclic nucleoside analog by asymmetric [3+2] cycloaddition
A technology of nucleoside analogs and five-membered carbon rings, which is applied in the fields of chemistry and medicine, can solve the problems of expensive raw materials and complicated processes, and achieve the effect of simple operation, mild reaction conditions, concise and practical synthesis methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The asymmetric cycloaddition reaction formula provided by the present invention is as follows:
[0026]
[0027] Take a Shurank tube, under the protection of nitrogen, with 5mol% Pd 2 (dba) 3 and 10 mol% of ligand L in freshly distilled CH 2 Cl 2 As a solvent, stir at room temperature for 20 min, then add α-base-substituted acrylate (0.05 mmol) and allyl cyclopropane (0.075 mmol, 1.5 eq) in sequence, and react at 25 degrees Celsius. Through thin-layer plate detection (TLC); the target product was obtained through column chromatography with a yield of 99%, ee1=91%, ee2=90%.
[0028] 1 HNMR (400MHz, CDCl 3 ):δ8.68(s,1H),8.34(s,1H),5.63-5.57(m,1H),5.02(d,J=17.2Hz,1H),4.93(d,J=10.4Hz,1H) ,4.23-4.16(m,2H),3.86(q,J=7.6Hz,1H),3.80(s,3H),3.72(s,3H),3.60(d,J=14.8Hz,1H),3.40( d, J=15.2Hz, 1H), 2.98(q, J=7.2Hz, 1H), 2.46(q, J=5.6Hz, 1H), 1.13(t, J=7.2Hz, 3H). 13 CNMR (100MHz, CDCl 3 ): δ171.4, 171.2, 169.2, 152.1, 151.5, 151.2, 144.1, 133.4, 131.4, 119.2, 62.9, 57.2, 5...
Embodiment 2
[0030]
[0031] Take a Shurank tube, under the protection of nitrogen, with 5mol% Pd 2 (dba) 3 and 10 mol% of ligand L in freshly distilled CH 2 Cl 2 As a solvent, stir at room temperature for 20 min, then add α-base-substituted acrylate (0.05 mmol) and allyl cyclopropane (0.075 mmol, 1.5 eq) in sequence, and react at 25 degrees Celsius. Through thin-layer plate detection (TLC); the target product was obtained through column chromatography with a yield of 80%, ee1=81.4%, ee2=72.5%.
[0032] 1 HNMR (400MHz, CDCl 3):δ7.87(s,1H),5.61-5.52(m,1H),5.17(s,2H),5.05(d,J=17.2Hz,1H),4.97(d,J=10.4Hz,1H) ,4.23-4.15(m,2H),3.77(s,3H),3.72(s,3H),3.52(d,J=15.2Hz,1H),3.31(d,J=14.8Hz,1H),2.85( q,J=7.2Hz,1H),2.57-2.51(m,2H),1.16(t,J=7.2Hz,3H). 13 CNMR (100MHz, CDCl 3 ): δ171.5, 171.5, 169.6, 158.5, 154.0, 141.2, 133.6, 118.9, 71.9, 62.6, 57.4, 53.4, 53.3, 49.3, 41.8, 37.2, 13.8. HRMS: exactmasscalcdforC 19 h 22 ClN 5 o 6 Na(M+Na) + requiresm / z474.1151, foundm / z474.1149. 1 HNMR (4...
Embodiment 3
[0034]
[0035] Take a Shurank tube, under the protection of nitrogen, with 5mol% Pd 2 (dba) 3 and 10 mol% of ligand L in freshly distilled CH 2 Cl 2 As a solvent, stir at room temperature for 20 min, then add α-base-substituted acrylate (0.05 mmol) and allyl cyclopropane (0.075 mmol, 1.5 eq) in sequence, and react at 25 degrees Celsius. Through thin-layer plate detection (TLC); the target product was obtained through column chromatography with a yield of 93%, ee1=90.5%, ee2=79.5%.
[0036] 1 HNMR (400MHz, CDCl 3 ):δ8.95(s,1H),8.77(d,J=7.6Hz,2H),8.35(s,1H),7.58-7.52(m,3H),5.71-5.63(m,1H),5.05( d,J=17.2Hz,1H),4.95(d,J=10.4Hz,1H),4.26-4.16(m,2H),3.91-3.86(m,1H),3.80(s,3H),3.70(s ,3H),3.65(d,J=15.2Hz,1H),3.43(d,J=15.2Hz,1H),2.98(q,J=6.8Hz,1H),2.54(q,J=5.2Hz,1H ), 1.13(t,J=7.2Hz,3H). 13 CNMR (100MHz, CDCl 3 ): δ171.5, 171.4, 169.7, 154.8, 152.0, 143.1, 133.8, 131.0, 129.7, 128.6, 118.8, 71.9, 70.0, 62.7, 57.3, 53.4, 53.4, 49.7, 42.3, 37.2, 13.9. 25 h 26 N 4 o 6 Na(...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com